Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MEREDITH, P. A")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 113

  • Page / 5
Export

Selection :

  • and

Trough/peak ratios for antihypertensive agents : the issues in perspectiveMEREDITH, P. A.Drugs (Basel). 1994, Vol 48, Num 5, pp 661-666, issn 0012-6667Article

Generic drugs : Therapeutic equivalenceMEREDITH, P. A.Drug safety. 1996, Vol 15, Num 4, pp 233-242, issn 0114-5916Article

Importance of trough : peak ratios in treatment of blood pressure in post-myocardial infarction and heart failure settingsMEREDITH, P. A.Journal of human hypertension. 1997, Vol 11, Num 1, pp 39-43, issn 0950-9240Conference Paper

Organ protection and optimal blood pressure controlMEREDITH, P. A.American journal of hypertension. 1995, Vol 8, Num 10, pp 59S-62S, issn 0895-7061, 2Article

The importance of sustained blood pressure controlMEREDITH, P. A.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 3, pp S7-S11Conference Paper

Trough : peak ratio : clinically useful or practically irrelevant ?ELLIOTT, H. L; MEREDITH, P. A.Journal of hypertension. 1995, Vol 13, Num 3, pp 279-283, issn 0263-6352Article

The description and prediction of antihypertensive drug response : an individualised approachDONNELLY, R; MEREDITH, P. A; ELLIOTT, H. L et al.British journal of clinical pharmacology. 1991, Vol 31, Num 6, pp 627-634, issn 0306-5251, 8 p.Article

Counter-regulatory effects of combined ACE inhibition and calcium antagonismDONNELLY, R; ELLIOTT, H. L; MEREDITH, P. A et al.British journal of clinical pharmacology. 1988, Vol 25, Num 4, issn 0306-5251, 525Article

How to evaluate the duration of blood pressure control : The trough :peak ratio and 24-hour monitoringMEREDITH, P. A.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 31, Num 2, pp S17-S21Conference Paper

An additive or syngergistic drug interaction : application of concentration-effect modelingMEREDITH, P. A; ELLIOTT, H. L.Clinical pharmacology and therapeutics. 1992, Vol 51, Num 6, pp 708-714, issn 0009-9236Article

Clinical pharmacokinetics of amlodipineMEREDITH, P. A; ELLIOTT, H. L.Clinical pharmacokinetics. 1992, Vol 22, Num 1, pp 22-31, issn 0312-5963Article

Pharmacokinetics of nifedipinePASANISI, F; MEREDITH, P. A; REID, J. L et al.International journal of clinical pharmacology research. 1985, Vol 5, Num 1, pp 63-66, issn 0251-1649Article

Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with anginaELLIOTT, H. L; MEREDITH, P. A.Journal of human hypertension. 2011, Vol 25, Num 1, pp 63-70, issn 0950-9240, 8 p.Article

Concentration-effect relationships and antihypertensive mechanisms : ketanserin in the treatment of essential hypertensionELLIOTT, H. L; MEREDITH, P. A.Journal of hypertension. 1990, Vol 8, pp S69-S71, issn 0263-6352, suppl. 4Conference Paper

Pharmacokinetic-pharmacodynamic relationships of α-adrenoceptor antagonistsDONNELLY, R; MEREDITH, P. A; ELLIOTT, H. L et al.Clinical pharmacokinetics. 1989, Vol 17, Num 4, pp 264-274, issn 0312-5963Article

The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjectsPASANISI, F; MEREDITH, P. A; REID, J. L et al.European journal of clinical pharmacology. 1985, Vol 29, Num 1, pp 21-24, issn 0031-6970Article

Concentration-effect analysis of antihypertensive drug response : focus on calcium antagonistsDONNELLY, R; ELLIOTT, H. L; MEREDITH, P. A et al.Clinical pharmacokinetics. 1994, Vol 26, Num 6, pp 472-485, issn 0312-5963Article

Concentration-effect analysis of antihypertensive drug responsesREID, J. L; MEREDITH, P. A.Hypertension (Dallas, Tex. 1979). 1990, Vol 16, Num 1, pp 12-18, issn 0194-911X, 7 p.Article

Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartanMEREDITH, P. A.The American journal of cardiology. 1999, Vol 84, Num 2A, pp 7K-12K, issn 0002-9149Article

Clinical pharmacokinetics of nifedipine : Implications for the care of the elderlyELLIOTT, H. L; MEREDITH, P. A.Drugs & aging. 1997, Vol 11, Num 6, pp 470-479, issn 1170-229XArticle

Antihypertensive drugs : individualized analysis and clinical relevance of kinetic-dynamic relationshipsDONNELLY, R; ELLIOTT, H. L; MEREDITH, P. A et al.Pharmacology & therapeutics (Oxford). 1992, Vol 53, Num 1, pp 67-79, issn 0163-7258Article

Calculation of trough-to-peak ratio in the research unit setting : Advantages and disadvantages. Questions and answersELLIOTT, H. L; MEREDITH, P. A; MYERS et al.American journal of hypertension. 1996, Vol 9, Num 10, pp S71-S75, issn 0895-7061, 2Conference Paper

Differential effects of ACE inhibiting drugs : evidence for concentration-, dose-, and agent-dependent responsesMACFADYEN, R. J; MEREDITH, P. A; ELLIOTT, H. L et al.Clinical pharmacology and therapeutics. 1993, Vol 53, Num 6, pp 622-629, issn 0009-9236Article

A comparative assessment of amlodipine and felodipine ER : pharmacokinetic and pharmacodynamic indicesBAINBRIDGE, A. D; HERLIHY, O; MEREDITH, P. A et al.European journal of clinical pharmacology. 1993, Vol 45, Num 5, pp 425-430, issn 0031-6970Article

Neurohormonal and blood pressure responses to low-dose infusion of an orally active renin inhibitor, Ro 42-5892, in salt-replete menDOIG, J. K; MACFADYEN, R. J; MEREDITH, P. A et al.Journal of cardiovascular pharmacology. 1992, Vol 20, Num 6, pp 875-880, issn 0160-2446Article

  • Page / 5